Doyle Thomas James sold 4,607 shares of Kura Oncology, Inc. at $10.50 for −$48.4k on Sep 28, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SVP, Finance & Accounting
SVP, Finance & Accounting
Filed Sep 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$48,360.60Shares × reported price
Shares traded
4,607Common Stock
Price per share
$10.50Reported price. Read footnotes for ranges.
% of reported position traded
3.13%This security and ownership context
Holdings after
142,428Direct
Trade date
Sep 28, 2026Sell
Filed
Sep 29, 2026, 6:30 PM ET1-day reporting delay
Accession
0001193125-26-407936Code S · Transaction 231312
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 147,035 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

KURA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
KURA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +17%1w ago +7.4%1d ago −0.4%
Returns since7d −2.5%30d −2.2%90d180d1y

Footnotes in full

F1: Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The one-year anniversary of the specified development milestone was determined to be met on September 27, 2026, resulting in the vesting of 1/6th of the underlying shares. F2: Includes 1,868 shares acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan.